Carrier Screening Market Size, Value, and Competitive Overview:
[180 Pages Research Report] The global Carrier Screening Market size was valued at USD 2.1 billion in 2023, and the market is projected to reach USD 4.5 billion by the end of 2030, with growth at a CAGR of 11.6% during the forecast report 2023-2030.
The Carrier Screening Market has emerged as a significant component of the genetic testing industry, witnessing substantial growth and evolving dynamics. Carrier screening plays a crucial role in identifying individuals who carry genetic mutations that could be passed on to their offspring, thereby enabling informed reproductive decisions.
The market is primarily driven by increasing awareness and adoption of carrier screening among individuals and couples planning for pregnancy. With advancements in genetic testing technologies and the availability of expanded carrier screening panels, more comprehensive and accurate screening options are becoming accessible to a larger population.
Moreover, the rising prevalence of genetic disorders and the growing emphasis on preventive healthcare are contributing to the market's expansion. Carrier screening offers insights into an individual's risk of passing on genetic conditions, allowing for proactive measures such as genetic counseling, assisted reproductive technologies, or prenatal interventions.
Additionally, technological advancements, such as the incorporation of next-generation sequencing and non-invasive prenatal testing, have enhanced the efficiency and accuracy of carrier screening. These advancements have not only improved the detection rate of carrier status but have also made the testing process more convenient and accessible.
Furthermore, strategic collaborations between genetic testing laboratories, healthcare providers, and regulatory bodies have facilitated market growth. These collaborations aim to standardize carrier screening practices, expand the test menu, and ensure quality control and patient safety.
In conclusion, the Carrier Screening Market is witnessing a significant growth driven by increasing awareness, technological advancements, and collaborative efforts. As more individuals and couples recognize the importance of genetic screening in family planning, the market is expected to continue its expansion, providing opportunities for improved reproductive decision-making and personalized healthcare.
The Carrier Screening Market is experiencing dynamic changes and advancements due to several factors influencing its growth. One of the key dynamics driving the market is the rapid advancements in genetic testing technologies. The development of high-throughput sequencing platforms and the decreasing costs of genetic testing have made carrier screening more accessible and affordable to a larger population.
Another dynamic factor is the increasing emphasis on personalized medicine and precision healthcare. Carrier screening enables individuals and couples to make informed decisions about family planning, reproductive options, and prenatal interventions. The integration of carrier screening into routine prenatal care is becoming more prevalent, leading to an expansion in the market.
Furthermore, there is a growing focus on expanding the scope of carrier screening panels. Traditionally, carrier screening focused on a limited number of genetic conditions. However, there has been a shift towards comprehensive and expanded carrier screening panels that cover a broader range of genetic disorders. This expansion is driven by advancements in genomic research and the identification of new genetic variants associated with various diseases.
Additionally, the regulatory landscape and guidelines for carrier screening are continuously evolving. Regulatory authorities are updating and revising guidelines to ensure standardized testing practices, quality control, and patient safety. These regulatory changes influence the market dynamics by providing a framework for testing laboratories and healthcare providers.
In conclusion, the Carrier Screening Market is characterized by dynamic changes driven by advancements in genetic testing technologies, the emphasis on personalized medicine, expanding screening panels, and evolving regulatory guidelines. As the field of genomics continues to progress, the market is expected to witness further developments and advancements, enhancing its impact on reproductive healthcare.
As per the report, the global Carrier Screening Market is segmented into Type, Application, and Regions. The report covers detailed information on market size, Share, Growth, Value, Volume Analysis, Demand analysis, new market entry, competition insights, market drivers, challenges, opportunities, and Restraints. Further, company profile analysis, company revenue, Strategies, Sales, company acquisition, partnership, mergers, latest trends in the industry, regional and country-level insights, and competitive intelligence data is provided in the research report.
Further, the global market is geographically divided into major regions, and countries including North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Further, major countries focused in the global study report: United States, Canada, United Kingdom, Spain, Germany, Italy, France, Mexico, Russia, Ukraine, China, Japan, South Korea, India, Singapore, Malaysia, Australia, Qatar, Kingdom of Saudi Arabia, South Africa, Brazil, Argentina, and other countries are covered in the research study.
by Type
• Expanded
• Targeted Disease
by Indication
• Cystic Fibrosis
• Tay-Sachs
• Gaucher Disease
• Sickle Cell Disease
• Spinal Muscular Atrophy
• Others
by Technology
• DNA Sequencing
• Polymerase Chain Reaction
• Microarrays
• Others
by End-Use
• Hospitals
• Laboratories
• Physician Offices & Clinics
• Others
Geographical Classification Analysis:
- North America
- Latin America
- Europe
- Middle East and Africa
- Asia Pacific
Regional Insights:
• North American market to remain in control over the global market during 2022-2030. In the North American region, the United States occupied the highest share of the market in this region, and the US country is projected to follow the same trend over the forecast time 2022-2030, followed by Canada.
• Europe holds the second largest share producer in the global Disposable Medical Sensors Market during the forecast period 2022-2030. Asia Pacific region is expected to be registered as the fastest-growing market in the global market by 2030.
• Most developing countries in Asia Pacific remain the focus of leading Disposable Medical Sensors companies, with a large portion of these companies investing in new entry and business expansion strategies
• The market in the Middle East and Africa is projected to show prominent growth opportunities in the coming years from 2023-2030. Due to the rising focus from the government of the Middle East and African countries on emerging healthcare infrastructure manufacturing and distribution are mostly contributing to the global market in the MEA region.
• The Latin American Disposable Medical Sensors Market registered a substantial share of the global market in 2022, and it is projected to remain its presence in the market.
• Myriad Genetics, Inc.
• Cepheid Inc.
• Illumina Inc
• Thermo Fisher Scientific Corp
• F. Hoffmann-La Roche Ltd.
• LabCorp Holdings
• Otogenetics
• MedGenome Labs Ltd.
• GeneTech Solutions Inc.
• Centogene N.V.
*List not exhaustive
1. Executive Summary
1.1 Introduction to Carrier Screening Markets
1.2 Carrier Screening Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in Carrier Screening Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Carrier Screening Market Trends
3.2 Key Carrier Screening Market Growth Drivers
3.3 Key Carrier Screening Market Growth Restraints
4 Carrier Screening Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. Carrier Screening Market Segmentation- Outlook by Type
5.1 Expanded Carrier Screening Market Outlook to 2030
5.2 Targeted Disease Carrier Screening Market Outlook to 2030
6. Carrier Screening Market Segmentation- Outlook by Indication
6.1 Cystic Fibrosis Market Outlook to 2030
6.2 Tay-Sachs Market Outlook to 2030
6.3 Gaucher Disease Market Outlook to 2030
6.4 Sickle Cell Disease Market Outlook to 2030
6.5 Spinal Muscular Atrophy Market Outlook to 2030
6.6 Others Market Outlook to 2030
7. Carrier Screening Market Segmentation- Outlook by Technology
7.1 DNA Sequencing Market Outlook to 2030
7.2 Polymerase Chain Reaction Market Outlook to 2030
7.3 Microarrays Market Outlook to 2030
7.4 Others Market Outlook to 2030
8. Carrier Screening Market Segmentation- Outlook by End-Use
8.1 Hospitals Market Outlook to 2030
8.2 Laboratories Market Outlook to 2030
8.3 Physician Offices & Clinics Market Outlook to 2030
8.4 Others Market Outlook to 2030
9. North America Carrier Screening Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 North America Carrier Screening Market Growth Opportunities
9.3 North America Carrier Screening Market Outlook by Application
9.4 North America Carrier Screening Market Outlook by Type
9.5 North America Carrier Screening Market Outlook by Country
9.6 United States Carrier Screening Market Outlook
9.7 Canada Carrier Screening Market Outlook
9.8 Mexico Carrier Screening Market Outlook
10. Europe Carrier Screening Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Europe Carrier Screening Market Outlook by Application
10.3 Europe Carrier Screening Market Outlook by Type
10.4 Europe Carrier Screening Market Outlook by Country
10.5 Germany Carrier Screening Market Outlook
10.6 France Carrier Screening Market Outlook
10.7 United Kingdom Carrier Screening Market Outlook
10.8 Spain Carrier Screening Market Outlook
10.9 Italy Carrier Screening Market Outlook
10.10 Other Europe Carrier Screening Market Outlook
11. Asia Pacific Carrier Screening Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 Asia Pacific Carrier Screening Market Outlook by Application
11.3 Asia Pacific Carrier Screening Market Outlook by Type
11.4 Asia Pacific Carrier Screening Market Outlook by Country
11.5 China Carrier Screening Market Outlook
11.6 Japan Carrier Screening Market Outlook
11.7 India Carrier Screening Market Outlook
11.8 Other Asia Pacific Carrier Screening Market Outlook
12. Latin America Carrier Screening Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Latin America Carrier Screening Market Outlook by Application
12.3 Latin America Carrier Screening Market Outlook by Type
12.4 Latin America Carrier Screening Market Outlook by Country
12.5 Brazil Carrier Screening Market Outlook
12.6 Argentina Carrier Screening Market Outlook
12.7 Other Latin America Carrier Screening Market Outlook
13. Middle East and Africa Carrier Screening Market Outlook and Opportunities to 2030
13.1 Market Snapshot, 2023
13.2 Middle East and AfricaCarrier Screening Market Outlook by Application
13.3 Middle East and AfricaCarrier Screening Market Outlook by Type
13.4 Middle East and AfricaCarrier Screening Market Outlook by Country
13.5 Saudi Arabia Carrier Screening Market Outlook
13.6 UAE Carrier Screening Market Outlook
13.7 South Africa Carrier Screening Market Outlook
13.8 Other Middle East and Africa Carrier Screening Market Outlook
14 Profiles of major Carrier Screening Companies
Myriad Genetics, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Cepheid Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Illumina Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Thermo Fisher Scientific Corp
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
F. Hoffmann-La Roche Ltd.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
LabCorp Holdings
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Otogenetics
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
MedGenome Labs Ltd.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
GeneTech Solutions Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Centogene N.V.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
15. Appendix
15.1 Publisher’s Expertise
15.2 List of Tables and Charts
15.3 List of Exhibits
15.4 Legal Disclaimer
by Type
• Expanded
• Targeted Disease
by Indication
• Cystic Fibrosis
• Tay-Sachs
• Gaucher Disease
• Sickle Cell Disease
• Spinal Muscular Atrophy
• Others
by Technology
• DNA Sequencing
• Polymerase Chain Reaction
• Microarrays
• Others
by End-Use
• Hospitals
• Laboratories
• Physician Offices & Clinics
• Others